Noom Overview

![Image11]

![Image10]

Noom is the leading behavior change company, empowering everyone, everywhere to live better longer—every day. We are building the future of preventive care.

![Image8]

Noom is built on the foundational truth that people want to be healthy

Percent of US Consumers Who Say
Wellness Is a “Top” or “Important” Priority

Noom has built a vertically integrated stack with engagement at its core.

VERTICALLY INTEGRATED INPUTS
At-Home Diagnostics
Wearable Passive Health Data
Integrated Pharmacy
Convenient Clinical Care
App-Driven Behavior Data

Durable

Outcomes

The problem with GLP-1s: Most people stop and regain the weight.

The real opportunity isn’t the medication. It’s the window it creates to build healthy habits.

11 in 12
stop within 3 years¹

18 months after
stopping GLP-1s, most regain the weight²

We surveyed ~5,000 current and former GLP-1 users to understand what’s really happening beyond the prescription.
¹https://www.noom.com/psychosocial-glp1-report/

What Noom’s data shows: GLP-1s open the door, habits help people walk through.

25%

more weight loss: highest vs. lowest app engagement quartile

78%

noticed improved bloodwork (A1C reduction most cited)

95%

said medication helped them adopt new healthy habits

![Image23]

Why GLP-1s specifically demand integrated behavior change.

ADHERENCE

Side Effects &

Discontinuation

GI adverse events affect 40–70% of users, driving early dropout. SmartDose titrates dosing based on weight-loss speed and side-effect profile to find the "lowest dose that works."

EFFICACY

Weight Loss

Outcomes

More weight is lost when healthy eating and exercise habits accompany medication. Higher weight loss drives better patient outcomes across every measured dimension.

BODY COMPOSITION

Beyond-the-Scale Durable Weight Loss

Muscle Mass

Retention

Rapid weight loss degrades lean mass. Protein intake and resistance training are essential—dose titration prevents excessively fast loss that accelerates muscle breakdown.

DURABILITY

Durable Weight Loss

Without behavioral intervention, weight returns within 18 months of stopping GLP-1s. Durable response is critical to payer and consumer confidence alike.

WELLBEING

Beyond-the-Scale Impact

GLP-1s + behavior change produce dramatic improvements in overall wellbeing and health-related quality of life—well beyond food and nutrition alone.

Noom's superpower is engagement:

3x the retention of HIMS/HERS and 5x the retention of Ro

Engagement drives results that last.

better weight maintenance at 6 months for the average Noom GLP-1 Rx Program member vs. typical GLP-1 users

![Image26]

Different populations; comparison shown for context, not as a head-to-head clinical study.

AI-first experiences transform Noom into a personalized health OS.

Wearable data surfaces real-time nudges, pairing personalized daily insights with the right daily habits to drive action

![Image32]
![Image28]
![Image33]
![Image29]

AI builds personalized Challenges and behavior plans in chat — configuring programs around specific member goals and preferences
![Image31]
![Image30]

AI helps members understand their biomarkers and what treatments and habits will help them improve – personalizing cross-sell at scale
![Image35]
![Image34]

Behavior Drives Savings:

With over 6.5 Million lives covered, Noom is saving employers and health plans thousands of dollars per member.

Noom partners with 5 of the top 20 health plans in the country and hundreds of enterprise clients with an average size of 13,000+ employees.

$1,219

average savings per member at 2 years for Healthy Weight

average savings per member at 2 years for DPP

projected ROI over 3
4.1x years for Noom Med

In a market full of prescribers, Noom’s trusted brand drives an engagement flywheel.

2026 Newsweek
Most Trusted Brand

![Image44]
5x enrollment rate for health plans compared to competitors

![Image44]
4.5/5 TrustScore across 66k reviews, TrustPilot
![Image42]

Beyond Weight: To drive everyday wellbeing, Noom addresses non-acute, high-salience, large-market conditions that improve with an integrated program of behavior change and medication.

¹ Includes dyslipidemia, hypertension, elevated Lp(a)

One proven patient engagement engine. Multiple markets.

Same platform. Proven behavior engine. Six large markets.

• Includes Gut Health, Muscle Health, Skin Health, Energy, Mood-Mindset-Stress, Inflammation
  ¹ https://www.marketdataenterprises.com/u-s-weight-loss-market-now-worth-90-billion-obesity-drug-sales-soar/

Noom is a highly engaging and effective platform with significant scale and growth.

Noom /nu:m/ n.

The leading behavior change company building the future of preventive care

![Image49]